Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcturus Therapeutics Holdings Inc ARCT

Healthcare Biotechnology
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid... see more

Recent & Breaking News (NDAQ:ARCT)

Alcobra's Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results

Globe Newswire September 10, 2013

Alcobra Ltd. to Present at the Stifel Nicolaus 2013 Annual Healthcare Conference on September 11th

Globe Newswire September 3, 2013

Alcobra Enrolls First Patient in Comparative Study of Executive Function Benefits in Patients With PI-ADHD

Globe Newswire August 26, 2013

Alcobra Ltd. Reports Second Quarter 2013 Results

Globe Newswire August 6, 2013

Alcobra Ltd. to Host ADHD Seminar in New York City on August 6, 2013

Globe Newswire July 30, 2013

Alcobra Ltd. Appoints Dr. Jonathan Rubin as Chief Medical Officer

Globe Newswire July 30, 2013

Alcobra Ltd. to Provide Second Quarter 2013 Financials and Business Update on August 6th

Globe Newswire July 24, 2013

Alcobra Ltd. Announces U.S. Patent Issuance

Globe Newswire June 24, 2013

Alcobra Ltd. [ADHD] to Ring The NASDAQ Stock Market Opening Bell in Celebration of Recent IPO

Globe Newswire June 5, 2013

Alcobra Ltd. to Ring the NASDAQ Stock Market Opening Bell on Thursday, June 6th

Globe Newswire June 3, 2013

Alcobra Ltd. Lists Shares on NASDAQ - Video Summary on InvestmentPitch.com

Newsfile May 31, 2013

Alcobra Ltd. (NASDAQ:ADHD) Lists on NASDAQ - Video Summary Posted on InvestmentPitch.com

Thomson Reuters ONE May 31, 2013

Alcobra Ltd. Announces Closing of Initial Public Offering

Globe Newswire May 28, 2013

Alcobra Ltd. to Present at Upcoming Investor Conferences

Globe Newswire May 28, 2013